Wiley Matthew T. 4
4 · BioXcel Therapeutics, Inc. · Filed Mar 16, 2023
Insider Transaction Report
Form 4
Wiley Matthew T.
Other
Transactions
- Award
Restricted Stock Units
2023-03-15+12,000→ 12,000 total→ Common Stock (12,000 underlying) - Award
Stock Option (Right to Buy)
2023-03-15+36,000→ 36,000 totalExercise: $19.60Exp: 2033-03-15→ Common Stock (36,000 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The RSUs will vest and settle as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of Restricted Stock Units at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
- [F3]The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of March 15, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.